From: Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
| Most important | Least important | ||||
|---|---|---|---|---|---|
| Efficacy and safety | 9 | 1 | |||
| Lack of sedation | 6 | 4 | |||
| Lack of psychomotor impairment | 6 | 3 | 1 | ||
| Adherence to treatment | 5 | 2 | 2 | 1 | |
| Lifestyle of patients (e.g., level of daily activity, type of employment) | 5 | 1 | 3 | 1 | |
| Concomitant disease | 4 | 2 | 2 | ||
| Costs of treatment | 3 | 3 | 3 | 1 | |
| Special patient populations | 3 | 4 | 2 | 1 | |
| Others: lack of cardiac side effects | 1 | ||||
| Others: previous antihistamines used | 1 | ||||